Преглед
Промяна на цената на акция
24 ч
Текуща
Минимум
46.75
Максимум
48.29
Приходи | 9.8M 16M |
|---|---|
Продажби | 21M 103M |
P/E Средно за сектора | 69.167 31.987 |
EPS | 0.31 |
Марж на печалбата | 15.468 |
Служители | 679 |
EBITDA | 13M 39M |
Препоръки | Силна покупка |
|---|---|
12-месечна прогноза | +23.1% upside |
Пазарна капитализация | 608M 2.7B |
|---|---|
Предишно отваряне | 47.95 |
Предишно затваряне | 47.66 |
IMAX Corp Графика
Миналото представяне не гарантира бъдещи резултати.
Свързани новини
5.11.2026 г., 23:56 ч. UTC
Rigel Pharmaceuticals reports Q3 2026 net income of $13.2 million, missing expectations, and revises full-year revenue guidance down to $290-$295 million.
Прочетени
5.11.2026 г., 23:51 ч. UTC
The Chefs' Warehouse, Inc. shares are moving lower after reporting third-quarter sales of $1.14 billion, amid a broader market decline.
Прочетени
5.11.2026 г., 23:51 ч. UTC
Century Aluminum reports Q3 net sales of $961.2 million, exceeding estimates, but adjusted EPS of $2.58 missed expectations of $2.75. Q4 EBITDA guidance set at $275M-$300M.
Прочетени
5.11.2026 г., 23:51 ч. UTC
Alector, Inc. reported Q3 earnings of $1.11 per share, exceeding estimates, with revenue of $162.87 million driven by collaboration with Glaxo Wellcome UK.
Прочетени
5.11.2026 г., 23:41 ч. UTC
JP Morgan maintains Underweight rating on Snap Inc and lowers price target to $5, contributing to the stock's decline in after-market hours.
Прочетени
5.11.2026 г., 23:41 ч. UTC
iRhythm Holdings reports Q3 adjusted EPS of $0.82, raises full-year 2026 sales guidance to $890M-$895M, but revenue misses estimates at $221.59M.
Прочетени
5.11.2026 г., 23:41 ч. UTC
Blue Owl Capital Inc. is moving lower in after-market hours amid a broader market decline, influenced by negative sentiment and recent economic data.
Прочетени
5.11.2026 г., 23:41 ч. UTC
BTIG maintains its Buy rating on LifeStance Health and raises its price target to $20, while Canaccord increases its target to $16.
Прочетени
5.11.2026 г., 23:41 ч. UTC
A securities class action lawsuit has been filed against Duolingo, Inc. by Levi & Korsinsky, LLP, alleging concealed issues with user growth and product quality.
Прочетени
5.11.2026 г., 23:36 ч. UTC
Arch Capital Group Ltd. increases its share repurchase program by $3 billion, raising total authorization to $3.6 billion, as detailed in an SEC filing.
Прочетени
5.11.2026 г., 23:36 ч. UTC
ARK Genomic Revolution ETF declined in after-market trading as several holdings reported larger-than-expected net losses, with Pacific Biosciences also falling modestly.
Прочетени
5.11.2026 г., 23:31 ч. UTC
e.l.f. Beauty, Inc. shares declined during after-market hours, moving lower alongside the broader market amid ongoing stock market volatility and falling Treasury yields.
Прочетени
5.11.2026 г., 23:31 ч. UTC
Sarepta Therapeutics reported Q3 adjusted EPS of $0.13 and revenue of $381.4 million, but projected Q4 revenue at Q3 levels, raising investor concerns.
Прочетени
5.11.2026 г., 23:31 ч. UTC
Yelp lowers fiscal year 2026 sales guidance to $1.455B-$1.460B and projects Q4 revenue of $347M-$352M, below consensus estimates.
Прочетени
5.11.2026 г., 23:31 ч. UTC
EverCommerce Inc reported Q3 earnings of $0.03, missing estimates, and lowered 2026 revenue guidance to $600 million from $612 million.
Прочетени
5.11.2026 г., 23:31 ч. UTC
Array Technologies Inc shares declined during after-market hours, following the broader market trend, despite earlier rebounding from a session low.
Прочетени
5.11.2026 г., 23:26 ч. UTC
Crocs, Inc. shares traded modestly lower in after-market hours despite raising its full-year 2026 guidance and reporting revenue growth for the third quarter.
Прочетени
5.11.2026 г., 23:26 ч. UTC
Citigroup maintains Neutral rating on Insulet Corporation and raises price target to $170, with shares trading lower in after-market hours.
Прочетени
5.11.2026 г., 23:22 ч. UTC
Credo Technology Group Holding Ltd shares are lower in after-market trading, influenced by disappointing earnings and guidance from major semiconductor companies.
Прочетени
5.11.2026 г., 23:22 ч. UTC
Vertex Pharmaceuticals is declining in after-market trading, influenced by broader market concerns and a drop in the iShares Biotechnology ETF (IBB).
Прочетени
5.11.2026 г., 23:22 ч. UTC
NVIDIA Corporation's stock fell sharply, losing approximately $451 billion in market value, marking its worst day since January 2025 amid a broader tech sell-off.
Прочетени
5.11.2026 г., 23:22 ч. UTC
TTM Technologies Inc is under investigation by Kirby McInerney LLP for potential federal securities law violations following disappointing fourth-quarter revenue guidance.
Прочетени
5.11.2026 г., 23:22 ч. UTC
Micron Technology board member Linnie M. Haynesworth will retire at the annual shareholders meeting on January 14, 2027, reducing the board to eight directors.
Прочетени
5.11.2026 г., 23:21 ч. UTC
Qualcomm's stock declined sharply after the company reported weak earnings and falling smartphone chip sales, contributing to a broader semiconductor selloff.
Прочетени
5.11.2026 г., 23:21 ч. UTC
Encore Capital Group, Inc. shares are higher in after-market trading following a strong Q3 earnings report, with GAAP EPS rising 76% to $5.57.
Прочетени
5.11.2026 г., 23:21 ч. UTC
Northern Oil and Gas reported Q3 adjusted EPS of $1.32, exceeding estimates, and raised its 2026 production outlook to 147k-150k boe/d.
Прочетени
5.11.2026 г., 23:16 ч. UTC
MasterBrand, Inc. reported a third-quarter net loss of $9.2 million and projected fourth-quarter adjusted EPS between -$0.12 and -$0.08, below consensus.
Прочетени
5.11.2026 г., 23:16 ч. UTC
Citigroup maintains Neutral rating on Rapid7, Inc. and raises price target to $16 in a report published after market hours.
Прочетени
5.11.2026 г., 23:12 ч. UTC
Bearish options activity surges with 126k contracts traded.
Прочетени
5.11.2026 г., 23:11 ч. UTC
Fluence Energy, Inc. faces a class action lawsuit from Levi & Korsinsky, LLP, over alleged false statements regarding its fiscal 2026 revenue guidance.
Прочетени
Сравнение с други в отрасъла
Ценова промяна
IMAX Corp Прогноза
Ценова цел
By TipRanks
12-месечна прогноза
Среден 59.25 USD 23.1%
Висок 64 USD
Нисък 50 USD
Според 9 анализатори от Wall Street, предложили 12-месечна ценова цел за IMAX Corp през последните три месеца.
Консенсусна оценка
By TipRanks
Силна покупка
9 ratings
7
Купи
2
Задържане
0
Продай
Според 9 анализатори, дали борсови рейтинги на IMAX Corp през последните 3 месеца.
Финанси
Продажбени и админисративни разходи
Оперативни разходи
Печалба преди облагане с данъци
Продажби
Разходи за продажби
Брутна печалба от продажби
Разходи за лихви по дълг
EBITDA
Оперативна печалба
$